Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Ypsomed Holding AG
0QLQYpsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. Address: Brunnmattstrasse 6, Burgdorf, Switzerland, 3401
Analytics
Objectif de Cours de WallStreet
151.38 CHFRatio C/B
72.4739Rendement du dividende
0.48 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés 0QLQ
Analyse des dividendes 0QLQ
Croissance des dividendes sur 5 ans
-53 %Croissance continue
2 annéesRatio de distribution Moyenne sur 5 ans
26 %Historique des dividendes 0QLQ
Valorisation des titres 0QLQ
financières 0QLQ
Résultats | 2019 | Dynamique |